Association between Early Immune-Related Adverse Events and Survival in Patients Treated with PD-1/PD-L1 Inhibitors

Background: Immune-related adverse events (irAEs) are side effects that reflect the activation of patients’ immune systems after treatment with immune checkpoint inhibitors (ICIs). However, there is no meta-analysis on the effect of early irAEs on patient survival. Thus, we assessed the association...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, You-Cheng, Zhu, Tian-Chen, Nie, Run-Cong, Lu, Liang-He, Xiang, Zhi-Cheng, Xie, Dan, Luo, Rong-Zhen, Cai, Mu-Yan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9917734/
https://www.ncbi.nlm.nih.gov/pubmed/36769385
http://dx.doi.org/10.3390/jcm12030736

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9917734/
https://www.ncbi.nlm.nih.gov/pubmed/36769385
http://dx.doi.org/10.3390/jcm12030736

Ejemplares similares